| Literature DB >> 29180914 |
Engy Shokry1, Nelson Roberto Antoniosi Filho1.
Abstract
Cerumen or earwax is an emerging bio-fluid in clinical diagnosis that has been very little exploited during the past decades in spite of its high diagnostic potential. It is highly abundant in diagnostic biomarkers such as genetic material, lipids, proteins, chemical elements, internal and external metabolites (e.g. hormones, volatile organic compounds, amino acids, xenobiotics etc.) reaching earwax from the blood circulation. Thus, it is able to reflect not only physiology, pathophysiology of the human body but can also detect recent and long term exposure to environmental pollutants, without the need of invasive blood tests and in the same time overcoming many disadvantages faced by using other diagnostic biological fluids. This review discusses the biology, functions, chemistry of earwax, past and current approaches for the study of its chemical composition, emphasizing how a detected variation in its composition can offer information of high clinical value, which can be useful in diagnosis of many diseases such as metabolic disorders and tumours as well as in forensic applications. It also presents details about techniques of sample collection, storage, and analysis. Moreover, it highlights concerns about the use of earwax for diagnostic purposes, which should be addressed to make earwax diagnostics a reality in the future.Entities:
Keywords: cerumen; genomics; laboratory diagnosis; metabolomics; proteomics
Mesh:
Substances:
Year: 2017 PMID: 29180914 PMCID: PMC5696747 DOI: 10.11613/BM.2017.030503
Source DB: PubMed Journal: Biochem Med (Zagreb) ISSN: 1330-0962 Impact factor: 2.313
Figure 1The Jobson-Horne probe, an effective curette for the removal of the dry and wet type earwax
Overview of the selected applications of cerumen analysis in laboratory diagnostics
| 2 female, | Small metal scoop | 1D-PAGE pre-fractionation, online SCX-fractionation | LC-MS/MS | chronic otitis externa, otomycosis, benign or malignant ear tumors, systemic diseases as (diabetic nephropathy, breast cancer) | zinc-alpha-2-glycoprotein | Qualitative | Plasma, | Feig | |
| 40 patients | Sterile swabs | Homogenization | Real-time | Diagnosis of Hepatitis B infection | Hepatitis B | 4.2 x 102 - 4.7 x 106 copies per sample | Serum | Kalcioglu | |
| 50 patients | Sterile spoon /sterile swabs | Homogenization | Real-time | Diagnosis of Hepatitis B infection | Hepatitis B | ND | Serum, | Parizad | |
| 35 patients | Sterile swabs | Homogenization | Real-time | Transmission of Hepatitis C infection | Hepatitis C | no copies per sample | Serum | Bayindir | |
| 8 patients | ND | Desiccation by electric plate at 110oC | Change in weight | Allergic rhinitis | Total volatile compounds | 28.4 ± 8.5 (43.8 ± 12.2 µg/g)* | Blood | Paiva | |
| 17 patients | ND | Desiccation by electric plate at 110oC | Change in weight | Otoschlerosis | Total volatile compounds | 31.1±10.4 (43.8±12.2 µg/g)* | - | Paiva | |
| 12 patients | ND | Desiccation by electric plate at 110 oC | Change in weight | Cancer | Total volatile compounds | 30.7 ± 10.3 (43.8 ± 12.2 µg/g)* | Blood, urine, saliva, sweat | Paiva | |
| Neonates | Metal scoop | Solvent extraction and derivatization | GC, | Maple | Sotolone (4,5-dimethyl-3-hydroxy-2[5H]-furanone), a metabolite of isoleucine or allo-isoleucine | Qualitative | Urine | Kataoka | |
| 2 females patients (61 years) | ND | Solvent extraction | Paper chromatography, visualization with 5% ammonium silver nitrate | Alkaptonuria | Homogentisic acid | Qualitative | Urine | Frohlich | |
| 26 patients (13 males, 13 females) | Plastic curette | No previous extraction | HS/GC-MS | Diabetes mellitus (Types 1 and 2) | Acetone, methoxyacetone, ethanol, isobutyraldehyde, hydroxyurea, acetic acid | Chemometric treatment of quantitative | Blood, plasma, | Shokry | |
| ND | ND | Solvent extraction | GC, | Exposure | Lindane, chlordane, DDT, DDE, dieldrin, HCB, HCH | Detected | Breath, blood (short term exposure), adipose tissue, breast milk (long-term exposure) | Lauwerys | |
| 3800 (35-54 years) | ND | Solvent extraction | GC, | DDT, HCH induced cancer mortality | DDT, HCH | Detected (0.0 µg/g)* | Breath, blood, adipose tissue | Wang | |
| 10 males and 7 females (≥ 18 years) | Plastic curette | Direct extraction with methanol | UPLC- | Administration of drugs of abuse or drug facilitated crimes | lacosamide | 13.2 ng/mg (0.0 ng/mg)* | Blood, plasma, urine, saliva (short term), hair (long term) | Shokry | |
| lamotrigine | 9.5 - 115.0 ng/mg (0.0 ng/mg)* | ||||||||
| carbamazepine | 13.2 - 259.5 ng/mg (0.0 ng/mg)* | ||||||||
| phenytoin | 8.7 - 243.3 ng/mg (0.0 ng/mg)* | ||||||||
| levitracetam | 52.0 ng/mg (0.0 ng/mg)* | ||||||||
| oxcarbazepine | 5.0 - 326.5 ng/mg (0.0 ng/mg)* | ||||||||
| valproic acid | 186.5 - 4850.0 pg/mg | ||||||||
| topiramate | 9.8 - 175.5 ng/mg | ||||||||
| clobazam | 186.5 - 4850 pg/mg (8.0 - 175.5 ng/mg) (0.0 pg/mg)* | ||||||||
| clonazepam | 5.6 - 8.4 ng/mg (0.0 ng/mg)* | ||||||||
| phenobarbital | 5.6 - 6.3 ng/mg (0.0 ng/mg)* | ||||||||
| clozapine | 31.7 ng/mg (0.0 ng/mg)* | ||||||||
| 38 postmortem samples | Cotton swab | Drying at room temperature for 24 h, solvent extraction | LC-TOF MS, LC-MS/MS | Drug abuse | Opiates, cannabinoids | 2-100 ng/ 0.42- | Blood, urine, hair, bile | Meier | |
| 24 females, 37 males (18-35 years) | Plastic curette | No sample pre-treatment | HS- | Tobacco use/exposure | Nicotine | 1.2 ± 0.5 ng/mg, passive | Blood, urine, saliva, sweat, hair, nails | Shokry | |
| Cotinine | 5.3 ± 2.9 ng/mg, passive | ||||||||
| Anabasine | 0.0 ng/mg, passive | ||||||||
| 3.7 ± 4.4 ng/mg passive | |||||||||
| 1 male, 1 | clean | Desiccation, digestion in 10% nitric acid | Inductively coupled plasma atomic emission spectroscopy | Exposure to toxic elements | Lead | 13.5 ± 0.71 μg/g (0.0 µg/g)* | Plasma, sweat, skin | Krishnan | |
| Cadmium | 1.14 ± 0.66 μg/g (0.0 µg/g)* | ||||||||
| 10 males, 10 females | ND | Incineration (for 6 hours) at 600oC | Flame Photometry | Fungal infection in the ear | Copper | 0 ng/100gm (0.942- 3.314 ng/100gm)* | - | Yassin | |
| 4 male, | Curette | Desiccation under vacuum, digestion in nitric/perchloric acid mixture (5:1 V/V) | Atomic absorption spectroscopy | Cystic fibrosis | Zinc | 118 ± 103 μg/g (1857 ± 1341 | Blood, urine, saliva, sweat | Brand-Auraban | |
| 17 patients | ND | Incineration in a muffle furnace at 550 °C for 12 hours, dissolving in HCl | Clark-Collip method | Allergic Rhinitis | Calcium | 6.87 ± 1.69 mEq/100 g (8.0 9± 1.86 mEq/100 g)* | Blood | Paiva | |
| Fiske-Subbarow method | Phosphorus | 26.9 ± 8.7 mg/100 g (18.63 ± 6.52 mg/100 g)* | |||||||
| Turbidimetric method | Sulfur | 510.9 ± 152.7 mg/100 g (223.9 ± 35.1 mg/100 g)* | |||||||
| Diethyldithio-carbamate method | Copper | 1.62 ± 0.49 mg/100 g (2.43 ± 1.29 mg/100 g)* | |||||||
| 12 patients | ND | Incineration in a muffle furnace at 550°C for 12 hours, dissolving in HCl | flame spectrophoto-metry | Cancer (prostate, mandible, tongue, tonsils, larynx) | Sodium | 29.15 ± 8.11 mEq/100 g (39.5 ± 14.42 mEq/100 g)* | Blood, serum, urine, saliva, sweat | Paiva | |
| Clark-CoUip method | Calcium | 5.59 ± 1.76 mEq/100 g (8.09 ± 1.86 mEq/100 g)* | |||||||
| Yellow titan | Magnesium | 1.84 ± 0.49 mEq/100 g (4.9 6± 2.56 mEq/100 g)* | |||||||
| Fiske-Subbarow method | Phosphorus | 89.7 ± 15.1 mg/100 g (18.63 ± 6.52 mg/100 g)* | |||||||
| 1 female (16 years), 2 males (22 and 28 years) | ND | ND | Histochemical | Wilson’s disease | Copper | 7.17 (2.43 mg/100 g)* | Serum, urine, faeces, cerebrospinal fluid, bile, saliva | Canelas | |
| 8 patients | ND | Incineration in a muffle furnace at 550 °C for 12 hours, dissolving in HCl | Clark-Collip method | Otosclerosis | Calcium | 9.43 ± 3.03 mEq/100 g (8.09 ± 1.86 mEq/100 g)* | - | Paiva | |
| flame spectrophotometry | Potassium | 32.24 ± 4.17 mEq/100 g (37.67 ± 17.99 mEq/100 g)* | |||||||
| 1D-PAGE – one-dimensional polyacrylamide gel electrophoresis. LC-MS/MS – liquid chromatography/tandem mass spectrometry. DNA – deoxyribonucleic acid. PCR – polymerase chain reaction. RNA - ribonucleic acid. GC – gas chromatography. HS/GC-MS - headspace gas chromatography/mass spectrometry. DDT – dichlorodiphenyltrichloroethane. DDE – dichlorodiphenyldichlororthylene. HCB – hexachlorobenzene. HCH – hexachlorocyclohexane. UPLC-MS/MS - ultra performance liquid chromatography - tandem mass spectrometry. *Reference ranges for the biomarkers studied. | |||||||||
Advantages and limitations of earwax testing for laboratory diagnostics
| Noninvasive, easy to collect, low cost | Despite its accessibility, it has not been widely and sufficiently studied as a bio fluid |
| No/minimum external contamination | Earwax composition shows a high inter-individual variability depending on many factors (sex, age, season, menstruation, |
| No risk of disease transmission as in blood sampling | Timely reproduction, since time (few days) is required for the build-up of the sample thus it is not suitable for continuous monitoring |
| No need for trained medical staff | |
| Samples are easy to ship and store | |
| No/minimum embarrassment or discomfort associated with blood and urine tests | Lack of standardized methods for earwax collection |
| Requires less sample pretreatment or manipulation for diagnostic tests | |
| Can detect both recent and long-term exposure unlike blood, urine, saliva, | Till now, cerumen analysis involves complicated instrumentation as GC–MS, LC-MS that requires trained personnel |
| Economical sampling, shipping and storage compared to blood | |
| Sampling can be done at home | |
| GC-MS – gas chromatography - mass spectrometry. LC-MS - liquid chromatography-mass spectrometry. | |